Project Grant R01NS136615

Award Date 7/17/24
Completion Date 5/31/29
Dollars Obligated $1.7M
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $789,088 to Children's Hospital Medical Center in Cincinnati, OH to develop a novel, less invasive tool for ablating the choroid plexus to treat neonatal hydrocephalus. The project aims to evaluate this tool in human choroid plexus organoids and rodent models, with the goal of...
The University of Alabama at Birmingham (UAB) has been awarded a $392,855 Project Grant (R21NS135321) from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to conduct research on the underlying genetic and cellular mechanisms of congenital hydrocephalus. The project aims to 1) comprehensively characterize germline and somatic genetic variations in hydrocephalus patients using...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the federal Child Health and Human Development Extramural Research program (CFDA 93.865), provides $607,274 to Children's Hospital of Orange County (CHOC) from August 1, 2025 to May 31, 2030. The funding supports a longitudinal study examining brain development trajectories, from birth to early adulthood, in individuals born very preterm (VP) compared to those born...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the pathogenic mechanisms of inflammatory subventricular zone injury in preterm infants. The $635,386 award to Duke University aims to define immune signatures associated with the development of subventricular zone echogenicity in preterm infants with...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports research to better understand the relationship between inflammation, white matter injury, and insulin-like growth factor-1 (IGF-1) in neonatal intraventricular hemorrhage (IVH). The $440,066 award to the Medical University of South Carolina, with sub-awards to the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $472,616 to Oregon Health & Science University (OHSU) to conduct research on mechanisms underlying memory impairment in preterm infants experiencing acute respiratory failure. The project aims to 1) determine if neonatal hypoxia disrupts hippocampal neuronal maturation...
This $296,108 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders will support research at the Scripps Research Institute to investigate how mechanosensation at the choroid plexus contributes to intracranial pressure (ICP) regulation in health and disease. The project aims to characterize the role of the mechanosensitive ion channel Piezo1 in choroid plexus...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD, CFDA 93.865 Child Health and Human Development Extramural Research program) provides $1,708,120.00 to Baylor College of Medicine to develop less invasive intervention strategies for in utero repair of spina bifida. The project aims to create a pro-regenerative environment within the amniotic cavity to activate cellular and molecular cascades that can reduce the severity of spina bifida...
The Trustees of Columbia University in the City of New York, through its Health Sciences Division, has been awarded a $452,375 Project Grant by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). This funding will support a 2-year research project to investigate the role of cerebral pericytes in age-related vasodilatory responses to inhaled anesthetics, and the potential link to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $296,108 to The Children's Hospital of Philadelphia (CHOP) to study the mechanisms of glial detection of axonal injury and facilitation of axonal regeneration. The project aims to define the origins of a novel glial response involving the release of large extracellular vesicles,...

RESTORATION OF EPENDYMAL INTEGRITY REDUCES POSTHEMORRHAGIC HYDROCEPHALUS IN PRETERM NEONATES - ABSTRACT ABOUT 27% OF PREMATURE INFANTS WEIGHING LESS THAN 1500 G DEVELOP INTRAVENTRICULAR HEMORRHAGE (IVH). THESE INFANTS SUFFER FROM POST-HEMORRHAGIC HYDROCEPHALUS, CEREBRAL PALSY, AND COGNITIVE DEFICITS. NO OPTIMAL THERAPY EXISTS TO PREVENT OR MINIMIZE POST-IVH HYDROCEPHALUS. IVH DAMAGES THE MULTICILIATED EPENDYMA IN THE CEREBRAL VENTRICLES AND AQUEDUCT DISRUPTING THE CILIA-DRIVEN CSF FLOW. MOREOVER, THIS INFLAMES THE CHOROID PLEXUS (CHP) AND PERIVENTRICULAR REGIONS, INCREASING CSF PRODUCTION AND CONTRIBUTING TO HYDROCEPHALUS. THE CEREBRAL VENTRICLE IN FETUSES IS LINED BY PSEUDOSTRATIFIED EPITHELIUM CONSISTING OF RADIAL GLIA AND OTHER NEURAL PROGENITORS. AS THE BRAIN MATURES, THE RADIAL GLIA DIFFERENTIATES INTO MULTICILIATED EPENDYMAL CELLS (E1) AND QUIESCENT NEURAL STEM CELLS (B1). THIS MULTICILIATED DIFFERENTIATION PROGRAM IS REGULATED BY MCIDAS>P73>FOXJ1 SIGNALING PATHWAY THAT REGULATES THE SPECIFICATION OF RADIAL GLIA INTO MULTICILIATED EPENDYMA. INDEED, HUMAN INFANTS WITH FOXJ1 OR MCIDAS MUTATION AND FOXJ1 KNOCK-OUT MICE DISPLAY DEFECTIVE MULTICILIATED EPENDYMA AND HYDROCEPHALUS. IVH INJURES THE EPENDYMA AND CHP, REDUCES THE PROLIFERATION OF PROGENITORS IN THE VENTRICULAR (VZ) AND SUBVENTRICULAR ZONE (SVZ), AND DOWNREGULATES SONIC HEDGEHOG (SHH) EXPRESSION IN THE PERIVENTRICULAR REGIONS. CONVERSELY, SHH OVEREXPRESSION PROMOTES THE PROLIFERATION OF PROGENITORS IN VZ AND SVZ, REDUCES INFLAMMATION, AND UPREGULATES FOXJ1, P73, AND RFX3 TRANSCRIPTION FACTORS, LIKELY PROMOTING REPAIR OF THE DAMAGED EPENDYMA AND CSF FLOW. OUR PRELIMINARY DATA SHOW THAT IVH REDUCES THE NUMBER OF E1 AND B1 CELLS. ADDITIONALLY, THE SHH ACTIVATION INCREASES THE POPULATION OF E1 AND B1 CELLS AND REDUCES THE VENTRICULAR VOLUME IN THE RABBIT MODEL OF IVH. WE HYPOTHESIZE THAT A) IVH RESULTS IN APOPTOSIS, REDUCTION, AND ARRESTED MATURATION OF MULTICILIATED EPENDYMAL CELLS IN PRETERM RABBITS AND HUMANS, AND B) ACTIVATION OF SHH/MCIDAS > FOXJ1 SIGNALING REVERSES THE DAMAGE TO THE CILIATED EPENDYMA AND REDUCES HYDROCEPHALUS IN KITS WITH IVH. OUR WELL-ESTABLISHED RABBIT MODEL OF IVH (E29 KITS) AND AUTOPSY SAMPLES FROM HUMAN PRETERM INFANTS WILL BE USED TO TEST THESE HYPOTHESES. IN AIM 1, WE WILL EVALUATE THE EFFECT OF IVH ON THE PROLIFERATION AND MATURATION OF THE EPENDYMA DEVELOPMENT IN PREMATURE RABBIT KITS (E29) AT POSTNATAL D3, 7, AND 14 BY IMMUNOHISTOCHEMISTRY AND ELECTRON MICROSCOPY. ALSO, THE PLANAR POLARITY OF CILIA IN IMMUNOSTAINED SECTIONS, CILIARY MOVEMENT, AND EPENDYMAL TRANSCRIPTOMIC CHANGES BY SCRNA-SEQ WILL BE ASSESSED. AUTOPSY SAMPLES FROM HUMAN FETUSES AND PREMATURE INFANTS (20-40 WEEKS) WILL BE ANALYZED TO ASSESS THE IMPACT OF GESTATIONAL AGE AND IVH ON THE CILIATED EPENDYMA DEVELOPMENT. IN AIM 2, WE WILL DETERMINE IF SHH ACTIVATION BY AD-SHH OR SMO-AGONIST TREATMENT REVERSES IVH-INDUCED EPENDYMAL DAMAGE, CILIARY LOSS, HYDROCEPHALUS, AND BEHAVIORAL DEFICITS BY INCREASING FOXJ1 EXPRESSION. IN AIM 3, WE WILL MODULATE MCIDAS>P73>FOXJ1 SIGNALING TO REVERSE THE EPENDYMAL INJURY, REDUCE HYDROCEPHALUS, AND ASSESS ITS IMPACT ON SHH-SIGNALING. THESE STUDIES SHOULD HASTEN THE DEVELOPMENT OF NEW THERAPIES FOR HYDROCEPHALUS AND EXPAND OUR UNDERSTANDING OF EPENDYMAL PLASTICITY IN PREMATURE NEWBORNS.

Posted 7/17/24